Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
10
10 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- FT-4202EtavopivatPhase 36 trials
Forma Therapeutics, Inc. · Sickle Cell Disease, Thalassemia
- Exa-celPhase 31 trial
Vertex Pharmaceuticals · Sickle Cell Disease, Hematological Diseases, Hemoglobinopathies
- IMR-687Tovinontrine, CRD-750Phase 23 trials
Cardurion Pharmaceuticals, Inc. · Heart Failure, Cardiovascular Diseases, Heart Diseases
- HBI-002Phase 22 trials
Hillhurst Biopharmaceuticals, Inc. · Parkinson Disease, Anemia, Sickle Cell
- TebapivatAG-946Phase 22 trials
Agios Pharmaceuticals, Inc. · Myelodysplastic Syndromes, Sickle Cell Disease
- AnumigilimabPhase 21 trial
CSL Behring · Sickle Cell Disease
- BEAM-101Phase 21 trial
Beam Therapeutics Inc. · Sickle Cell Disease
- BMS-986470Phase 21 trial
Bristol Myers Squibb · Anemia, Sickle Cell, Healthy Volunteers
- CSL889Phase 21 trial
CSL Behring · Sickle Cell Disease Vaso-occlusive Crisis
- ITU512Phase 21 trial
Novartis · Sickle Cell Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.